Price target
80.240.000.00%
The 25 analysts offering 1 year price forecasts for CRSP have a max estimate of — and a min estimate of —.
Analyst rating
Based on 31 analysts giving stock ratings to CRSP in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
CRSP EPS for the last quarter is −1.01 USD despite the estimation of −1.38 USD. In the next quarter EPS is expected to reach −1.26 USD. Track more of CRISPR Therapeutics AG financials and stay on top of what is up with the company.
In the next quarter CRISPR Therapeutics AG revenue is expected to reach 9.08 M USD. Check out CRISPR Therapeutics AG revenue and earnings and make informed decisions.
According to analysts, CRSP price target is 80.24 USD with a max estimate of 199.00 USD and a min estimate of 30.00 USD. Check if this forecast comes true in a year, meanwhile watch CRISPR Therapeutics AG stock price chart and keep track of the current situation with CRSP news and stock market news.
We've gathered opinions of 31 analysts rating CRSP stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.